Ova donors demand compensation from government
By Asia News,
AsiaNews.it
| 02. 07. 2006
Seoul (AsiaNews) _ A coalition of 35 women_s groups filed a suit for compensation against the South Korean government on behalf of women suffering from side-effects after making uninformed ova donations to Prof Hwang Woo-suk for his research on stem cell embryos.
The women_s groups in association with Lawyers for a Democratic Society (Minbyun) claim that the donors who provided the _research material_ to the now disgraced researcher received no information on the side effects of excessive ova collection.
During the investigation into the fraudulent study, it was found that Hwang_s team used 2,221 ova, about fivefold the number Hwang had previously claimed, and that about 20 per cent of the donors have suffered side-effects from this invasive practice.
_Fifteen women donated eggs more than twice. The Mizmedi Hospital team even collected ova twice from a woman, who was hospitalized for side-effects after each donation,__ the women_s groups said in a statement. _It is an example of how the embryonic stem cell research, which received full national support, trampled on women_s human rights,_ the press release also said.
The groups...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Charles Schmidt, Undark | 09.25.2026
In 2010, scientists at the University of Tokyo and other institutions reported a startling achievement: They had successfully grown a pancreas made almost entirely of rat cells within the bodies of mice. The research was directed by Hiromitsu Nakauchi, a...
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...